NC
SFE

Northpointe Capital’s Safeguard Scientifics, Inc. SFE Stock Holding History

Northpointe Capital’s Portfolio SFE Stock Details SFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-165,185
Closed -$2.65M – 251
2013
Q2 		$2.65M Buy
+165,185
New +$2.63M 0.31% 85

Other funds holding SFE

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
FCAM
F&C Asset Management Edinburgh, Scotland, United Kingdom $7.92B AUM 24.35% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Northpointe Capital's SFE Position: Q3 2013 in Review

Northpointe Capital sold out of Safeguard Scientifics, Inc. (SFE) in Q3 2013, closing a stake of 165,185 shares — an estimated $2.65M sold.

Northpointe Capital first reported a position in SFE in Q2 2013 and held it in 1 quarter. The position peaked at $2.65M in Q2 2013. 97 funds tracked by Wall St. Rank hold SFE as of Q3 2013.

  • Northpointe Capital reported no remaining Safeguard Scientifics, Inc. position as of Q3 2013 after selling out during the quarter.
  • Northpointe Capital sold 165,185 Safeguard Scientifics, Inc. shares in Q3 2013, an estimated $2.65M.
  • Northpointe Capital first reported a position in Safeguard Scientifics, Inc. in Q2 2013 and held it in 1 quarter.
  • Northpointe Capital's Safeguard Scientifics, Inc. position peaked at $2.65M in Q2 2013.
  • 97 funds tracked by Wall St. Rank held Safeguard Scientifics, Inc. as of Q3 2013.

Based on Northpointe Capital's 13F filing for Q3 2013, filed 7 Nov 2013.